----
Current ValuationThe current P/E ratio is 6.24, within the reasonable range, cheaper than 68.12% of the time in the past 5 years, and the industry ranks 1/22, the industry Median 6.24.
6.24xP/E
HK$16.68Stock price
HK$2.67Earnings per share
6.24xP/E
Stock priceHK$16.68Earnings per shareHK$2.67
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 6.69x
- Typical range
- 5.98x–7.66x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 6.24x
05101520
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 6.24x
0x10x20x30x40x50x
| Name/Symbol | |||
|---|---|---|---|
01099HKSINOPHARM | 6.24x | 10.33% | HK$52.05B |
02607HKSH PHARMA | 6.90x | -- | HK$41.53B |
00874HKBAIYUNSHAN PH | 8.53x | 1.99% | HK$21.51B |
06833HKSINCO PHARMA | 6.98x | -- | HK$243.95M |
03390HKTYCOON GROUP | 7.09x | -- | HK$218.14M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
